Skip to main content
logo
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
9.38
+0.08 (0.86%)
At close: Aug 7, 2026, 4:00 PM EDT
9.42
+0.04 (0.43%)
After-hours: Aug 7, 2026, 7:51 PM EDT

BioCryst Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,3971,6621,5681,2332,1572,553
Market Cap Growth
32.77%5.97%27.23%-42.86%-15.51%93.75%
Enterprise Value
2,8811,8642,0891,6922,4762,640
Last Close Price
9.387.807.525.9911.4813.85
PE Ratio
-6.45----
Forward PE
22.7833.02----
PS Ratio
2.551.903.483.727.9716.25
PB Ratio
--13.95-3.30-2.71-7.32-23.87
P/FCF Ratio
6.424.82----
P/OCF Ratio
6.374.78----
EV/Sales Ratio
3.062.134.635.119.1416.80
EV/EBITDA Ratio
-5.45----
EV/EBIT Ratio
-5.47----
EV/FCF Ratio
7.725.41----
Debt / Equity Ratio
-1.84-3.99-1.76-1.86-2.51-5.53
Debt / EBITDA Ratio
-1.39----
Debt / FCF Ratio
2.271.38----
Net Debt / Equity Ratio
-1.09-1.70-1.09-1.01-1.08-0.81
Net Debt / EBITDA Ratio
-0.450.59-401.36-4.50-2.17-0.49
Net Debt / FCF Ratio
1.330.59-9.79-4.72-1.95-0.60
Asset Turnover
0.301.740.890.620.480.34
Inventory Turnover
3.652.830.670.160.300.63
Quick Ratio
2.221.952.492.974.505.18
Current Ratio
2.322.062.633.314.905.46
Return on Equity (ROE)
134.16%-88.68%19.08%60.40%123.07%291.59%
Return on Assets (ROA)
-206.04%66.99%-0.52%-19.47%-26.38%-38.99%
Return on Invested Capital (ROIC)
-357.02%103.83%-0.75%-25.60%-32.32%-50.43%
Return on Capital Employed (ROCE)
-328.10%105.22%-0.73%-25.56%-31.96%-49.82%
Earnings Yield
-15.51%----
FCF Yield
15.58%20.75%----
Buyback Yield / Dilution
-10.24%-5.75%-7.54%-3.38%-3.79%-7.08%
Total Shareholder Return
-10.24%-5.75%-7.54%-3.38%-3.79%-7.08%
SEC Filings: 10-K · 10-Q